More failure with solanezumab – this time in preclinical Alzheimer’s disease

.

Source: Expert Opinion on Biological Therapy - March 4, 2024 Category: Drugs & Pharmacology Authors: Sheila A DoggrellSchool of Pharmacy and Medical Sciences, Gold Coast Campus, Griffith University, Gold Coast, Queensland, Australia Source Type: research